Application of the magnetic resonance 3D multiecho Dixon sequence for quantifying hepatic iron overload and steatosis in patients with thalassemia.

Iron Liver Magnetic resonance imaging Quantify Thalassemia

Journal

Magnetic resonance imaging
ISSN: 1873-5894
Titre abrégé: Magn Reson Imaging
Pays: Netherlands
ID NLM: 8214883

Informations de publication

Date de publication:
14 Mar 2024
Historique:
received: 26 01 2024
revised: 02 03 2024
accepted: 13 03 2024
medline: 17 3 2024
pubmed: 17 3 2024
entrez: 16 3 2024
Statut: aheadofprint

Résumé

To investigate the feasibility and diagnostic efficacy of a 3D multiecho Dixon (qDixon) research application for simultaneously quantifying the liver iron concentration (LIC) and steatosis in thalassemia patients. This prospective study enrolled participants with thalassemia who underwent 3 T MRI of the liver for the evaluation of hepatic iron overload. The imaging protocol including qDixon and conventional T2* mapping based on 2D multiecho gradient echo (ME GRE) sequences respectively. Regions of interest (ROIs) were drawn in the liver on the qDixon maps to obtain R2* and proton density fat fraction (PDFF). The reference R2* value was measured and calculated on conventional T2* mapping using the CMRtools software. Correlation analysis, Linear regression analysis, and Bland-Altman analysis were performed. 84 patients were finally included in this study. The median R2*-ME-GRE was 366.97 (1/s), range [206.68 (1/s), 522.20 (1/s)]. 8 patients had normal hepatic iron deposition, 16 had Insignificant, 42 had mild, 18 had moderate. The median of R2*-qDixon was 376.88 (1/s) [219.33 (1/s), 491.75 (1/s)]. A strong correlation was found between the liver R2*-qDixon and the R2*-ME-GRE (r = 0.959, P < 0.001). The median value of PDFF was 1.76% (1.10%, 2.95%). 8 patients had mild fatty liver, and 1 had severe fatty liver. MR qDixon research sequence can rapidly and accurately quantify liver iron overload, that highly consistent with the measured via conventional GRE sequence, and it can also simultaneously detect hepatic steatosis, this has great potential for clinical evaluation of thalassemia patients.

Identifiants

pubmed: 38492786
pii: S0730-725X(24)00071-7
doi: 10.1016/j.mri.2024.03.015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors of this manuscript declare no relationships with pharmaceutical companies, biomedical device manufacturers or other corporations whose products or services may be related to the subject matter of the article.

Auteurs

Fanyu Zhao (F)

Department of Radiology, Minzu Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, 530001, China.

Yidi Chen (Y)

Department of Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.

Ting Zhou (T)

Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530001, China.

Cheng Tang (C)

Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530001, China.

Jiang Huang (J)

Department of Radiology, Minzu Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, 530001, China.

Huiting Zhang (H)

MR Research Collaboration, Siemens Healthineers Ltd., Wuhan, China. Electronic address: huiting.zhang@siemens-healthineers.com.

Stephan Kannengiesser (S)

MR Research Collaboration, Siemens Healthineers Ltd., Wuhan, China. Electronic address: stephan.kannengiesser@siemens-healthineers.com.

Liling Long (L)

Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530001, China. Electronic address: cjr.longliling@vip.163.com.

Classifications MeSH